| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Medicine, Chiba University School of Medicine, Chiba [K. O.]; Division of Epidemiology, Center for Adult Diseases, Osaka [I. F., A. H.]; and Department of Pathology, Faculty of Medicine, University of Tokyo, Tokyo, Japan [Y. U.]
A trend in the incidence of hepatocellular carcinoma (HCC) in Japan was studied from the data of the Osaka Cancer Registry (population, 8,512,351 in 1981) for the period of 1963–1983, the Vital Statistics of Japan, Ministry of Health and Welfare, and the Japan Autopsy Registry which contained 594,132 individually filed cases in the 26-year period from 1958 to 1983. Both cancer registry data and autopsy records showed a more than 2-fold increase in HCC incidence, particularly in the last 10 years or so, among males and a less pronounced increase in females. The same trend was borne out by the cancer registries of Nagasaki City and Miyagi Prefecture and the Vital Statistics. When studied with the autopsy data, it was found that the numbers of autopsies for cirrhosis without HCC and autopsies for HCC (with and without cirrhosis) were about the same in 1958–1961 and that currently (1980–1983) the latter is about 2 times the former. As one of the possible causes of increase in HCC incidence other than prolonged survival of patients with cirrhosis, chronic non-A, non-B hepatitis is discussed.
1 To whom requests for reprints should be addressed, at Department of Medicine, Chiba University Hospital, Chiba, Japan (280).
Received 6/26/86. Revised 2/18/87. Revised 5/28/87. Accepted 6/16/87.
This article has been cited by other articles:
|
|
 |
|
  T. M. Pawlik, R. T. Poon, E. K. Abdalla, D. Zorzi, I. Ikai, S. A. Curley, D. M. Nagorney, J. Belghiti, I. O.-L. Ng, Y. Yamaoka, et al. Critical Appraisal of the Clinical and Pathologic Predictors of Survival After Resection of Large Hepatocellular Carcinoma Arch Surg, May 1, 2005; 140(5): 450 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shibuya and E. Yano Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001 Int. J. Epidemiol., April 1, 2005; 34(2): 397 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Cheung, K. L. Leung, Y. C. Ip, X. Chen, D. Y. Fong, I. O. Ng, S. T. Fan, and S. So Claudin-10 Expression Level is Associated with Recurrence of Primary Hepatocellular Carcinoma Clin. Cancer Res., January 15, 2005; 11(2): 551 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. El-Serag, J. A. Davila, N. J. Petersen, and K. A. McGlynn The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update Ann Intern Med, November 18, 2003; 139(10): 817 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S D Ryder Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults Gut, May 1, 2003; 52(90003): iii1 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 C.-A. Sun, D.-M. Wu, C.-C. Lin, S.-N. Lu, S.-L. You, L.-Y. Wang, M.-H. Wu, and C.-J. Chen Incidence and Cofactors of Hepatitis C Virus-related Hepatocellular Carcinoma: A Prospective Study of 12,008 Men in Taiwan Am. J. Epidemiol., April 15, 2003; 157(8): 674 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Kim and X. W. Wang Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis, March 1, 2003; 24(3): 363 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamamoto, Y. Tomita, S. Nakamori, Y. Hoshida, H. Nagano, K. Dono, K. Umeshita, M. Sakon, M. Monden, and K. Aozasa Elevated Expression of Valosin-Containing Protein (p97) in Hepatocellular Carcinoma Is Correlated With Increased Incidence of Tumor Recurrence J. Clin. Oncol., February 1, 2003; 21(3): 447 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yoshida, N. Kato, Y. Shiratori, R. Shao, Y. Wang, S. Shiina, and M. Omata Weak Association between SEN Virus Viremia and Liver Disease J. Clin. Microbiol., September 1, 2002; 40(9): 3140 - 3145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Maruyama, N. Nagasue, D. K. Dhar, A. Yamanoi, O. N. El-Assal, K. Satoh, and K. Okita Preventive Effect of FK143, a 5{{alpha}}-Reductase Inhibitor, on Chemical Hepatocarcinogenesis in Rats Clin. Cancer Res., July 1, 2001; 7(7): 2096 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsutsumi, H. Kitada, K. Shiraiwa, M. Takahama, T. Tsujiuchi, H. Sakitani, Y. Sasaki, K. Murakawa, M. Yoshimoto, and Y. Konishi Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats Carcinogenesis, February 1, 2000; 21(2): 251 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. El-Serag and A. C. Mason Rising Incidence of Hepatocellular Carcinoma in the United States N. Engl. J. Med., March 11, 1999; 340(10): 745 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Shimizu, M Yasuda, Y Mizobuchi, Y-R Ma, F Liu, M Shiba, T Horie, and S Ito Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats Gut, January 1, 1998; 42(1): 112 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Resnick and R. Koff Hepatitis C-Related Hepatocellular Carcinoma: Prevalence and Significance Arch Intern Med, July 26, 1993; 153(14): 1672 - 1677. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
